פרופ' ג'מאל מחאג'נה
Prof. Jamal Mahajna
-
*Orgil, O, Spector L, Holland D, Mahajna J, Amir R. (2016). The antiproliferative and anti-androgenic activity of different pomegranate accessions. Journal of Functional Foods 26, 517-528
-
Mian A.A., Heberboseh, I., Kidan, N.,Khamaisie, H., Regev, O., Nickola, M., Gal, M., Bloch, E., Ratiei, A., Silani, D., Ottman, O., Biondi, R., Ruthardt, M. and Mahajna J*. (2015). Potential use of allosteric inhibitors as strategy to overcome drug resistance in Ph-positive leukemia. International Journal of Molecular Medicine 36, S26-S26.
מענקים ופרסים | Grants and Awards
Israel Ministry of Science
Natural products as modulators of NFKB activity to improve HSVtk-based cancer gene therapy Mushroom Substances As anticancer Agents
Agency for Galilee Bio-Medical Research
Evaluation of Nephrotoxicity of Novel Platinum (IV)-Fatty Acid Conjugates in in vitro and in animal model.
DFG (Trilateral Palestinian-Israel-German Project)
Targeting the Myristoyl Binding Pocket (MBP) in Bcr-Abl: A Rational Approach for the Design of Therapeutics Against Philadelphia Chromosome
בשיתוף עם Dr. Yousef Najajreh, Al-Quds University, Prof. Amiram Goldblum, Hebrew University, Prof. Martin Ruthardt, Goethe University
ICRF
Natural Products to overcome Imatinib-refractory CML
Israel Cancer Association
Risk assessment of herb-chemotherapy interactions in women with gynecological cancer using herbs during chemotherapy: an integrated clinical and basic science study,
בשיתוף עם Prof. Eran BenArye, Technion
Israel Ministry of Science
Botanical steroids as potential prostate cancer therapeutics
Israel Ministry of Science
Mushroom Substances As anticancer Agents
Israel Ministry of Science
Overcoming acquired resistance in molecular therapy: inhibition of alternative pathways in Gleevec-refractory CML
Israel Ministry of economics, Kamin program
Development of allosteric inhibitors targeting novel regulatory elements for cancer therapy
Israeli Ministry of Health
Tumor microenvironment mediated drug resistance in ovarian cancer
Israeli Ministry of Negev and Galilee
The role of ROR kinase family in hematological malignance
Israeli-Palestinian Science Foundation (IPSO)
Targeting the Myristoyl Binding Pocket (MBP) in Bcr-Abl: A Rational Approach for the Design of Therapeutics Against Philadelphia Chromosome
בשיתוף עם Dr. Yousef Najajreh, Al-Quds University, Prof. Amiram Goldblum, Hebrew University